MetaCap

iTonic (ITOC) vs Nuwellis (NUWE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

iTonic is the larger company by market cap ($11.6 million vs $1.8 million), about 6.3 times the size. Nuwellis converts more of its revenue into profit, with a net margin of -211.9% versus -974.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ITOC-61.69%NUWE+393.70%
+797%+346%-105%
Oct 7, 20261 yearNov 20, 2026
ITOC-60.89%NUWE+394.92%
+764%+332%-100%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ITOC versus NUWE key metrics
MetricITOCNUWE
Share price$1.59$3.41
Market cap$11.63M$1.84M
1-day change+6.00%-10.50%
YTD return-76.40%—
1-year return-81.96%—
P/E ratio (TTM)—0.00
EPS (TTM)$-4.22$3,609.63
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$523.03K$8.27M
Revenue growth (YoY)+16.70%-5.38%
Net income (latest FY)$-5.10M$-17.52M
Gross margin62.59%61.96%
Operating margin-991.71%-134.29%
Net margin-974.68%-211.86%
52-week high$18.40$1,556.10
52-week low$1.40$2.52
Distance from 52-week high-91.36%-99.78%
Average volume42.84K829.19K
Shares outstanding6.84M540.91K
Employees738
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • iTonic is about 6.3 times larger than Nuwellis by market value ($11.63M vs $1.84M).
  • Nuwellis is more profitable, keeping -211.9 cents of every revenue dollar as net income versus -974.7 cents for iTonic.
  • iTonic grew revenue faster in its latest fiscal year (+16.70% vs -5.38%).

About iTonic

ITOC stock →

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 7 employees

About Nuwellis

NUWE stock →

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 38 employees

ITOC vs NUWE FAQ

Which is bigger, iTonic or Nuwellis?

iTonic (ITOC) is larger, with a market capitalization of $11.63M compared with $1.84M for Nuwellis (NUWE).

Are iTonic and Nuwellis in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons